Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Improved Child Nutrition and Development Through Social Transfers (TENDER)

28 april 2026 uppdaterad av: Jordyn Wallenborn, Swiss Tropical & Public Health Institute

Taabo Enhanced Nutrition and Development Through Economic Rewards

The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:

  • Does the social transfer increase complementary breastfeeding rates at 24-months postpartum?
  • Does the social transfer increase complementary breastfeeding duration?
  • Does the social transfer impact child health and development?
  • Does the social transfer impact maternal physical and mental health?

Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.

Participants will:

Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Beräknad)

1040

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  1. Are enrolled in the Taabo multigenerational birth cohort (MGC)
  2. Completed the postpartum interview of the Taabo MGC
  3. Have a child who is within two weeks of their 12-month birthday,
  4. are breastfeeding at time of recruitment,
  5. live in the Taabo HDSS, Côte d'Ivoire
  6. have no illnesses that contraindicates breastfeeding,
  7. had a healthy singleton infant with a birth weight of at least 2500 grams, and
  8. agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent

Exclusion Criteria:

  1. Plans to move permanently outside study area
  2. Has a medical, intellectual or psychological disability
  3. Contraindication for breastfeeding
  4. Children born with < 2500 grams

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Social Transfer
A social transfer is provided at the 24-month visit, conditional on the mother still breastfeeding at the time of the visit. They also receive education about current breastfeeding recommendations.
Övrig: Social Transfer
A social transfer will be given conditioned upon breastfeeding at 24-months postpartum.
Inget ingripande: Control
No intervention is provided besides education on current breastfeeding recommendations.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Prevalence of Complementary Breastfeeding
Tidsram: from 12 to 24 months postpartum
Prevalence of complementary breastfeeding at 24 months postpartum.
from 12 to 24 months postpartum
Complementary Breastfeeding Duration
Tidsram: from 12 to 24 months postpartum
Duration of complementary breastfeeding in weeks.
from 12 to 24 months postpartum

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Weight-for-Age z-score
Tidsram: 12 months; 24 months
Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores.
12 months; 24 months
Child Health Outcomes
Tidsram: 12 months; 24 months
We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use.
12 months; 24 months
Percent weight loss
Tidsram: 12 months; 24 months;
Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100.
12 months; 24 months;
Mother and Child Hemoglobin Levels
Tidsram: 12 months; 24 months
We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome.
12 months; 24 months
Maternal Depression
Tidsram: 12 months; 24 months
Maternal postpartum depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9); categorized as a binary: no depression (score <10) or depression present (score ≥10).
12 months; 24 months
Height-for-age z-score
Tidsram: 12 months; 24 months
Height will be measured in centimeters by using a Height Measuring Device, stadiometer, 20-205cm. All measurements will be analyzed as age standardized z-scores
12 months; 24 months
Mid-upper arm circumference (MUAC)
Tidsram: 12 months; 24 months
Infants will be measured for mid-upper arm circumference (MUAC) using non-stretchable measuring tape. All measurements will be analyzed as age standardized z-scores.
12 months; 24 months
Mother and Child Anemia
Tidsram: 12 months; 24 months
The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Hemoglobin levels (gm/dL) will be used to categorize mothers and children into a binary variable: anemic or not anemic.
12 months; 24 months
Maternal weight change
Tidsram: 12 months; 24 months;

Weight weight change will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Maternal weight change will be calculated as the difference between postpartum weight and pregnancy weight. Because pregnancy weight varies by gestational age, analyses will control for gestational age at pregnancy weight measurement and time postpartum at outcome measurement.

Categorized as: no weight loss (0 kg); moderate weight loss (<0 to >-5 kg); high weight loss (≥-5 kg); moderate weight gain (>0 to <5 kg); high weight gain (≥5 kg).
12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Tidsram: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be categorized as low, normal, or high according to standard clinical thresholds.
12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Tidsram: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be analyzed as a continuous measure.
12 months; 24 months;
Caregiver Reported Early Development Instruments (CREDI) cognitive z-score
Tidsram: 12 months; 24 months
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
12 months; 24 months
CREDI language z-score
Tidsram: 12 months; 24 months
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
12 months; 24 months
CREDI motor z-score
Tidsram: 12 months; 24 months
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
12 months; 24 months
CREDI social-emotional z-score
Tidsram: 12 months; 24 months
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
12 months; 24 months
Maternal Anxiety
Tidsram: 12 months; 24 months
Maternal postpartum anziety will be assessed using the the GAD-7 (Generalized Anxiety Disorder-7); a seven-item self-report questionnaire designed to measure the severity of anxiety; categorized as: Minimal Anxiety: score 0-4; Mild Anxiety: score 5-9; Moderate Anxiety: score 10-14; Severe Anxiety: score 15-21
12 months; 24 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Swiss Tropical & Public Health Institute

Samarbetspartners

Centre Suisse de Recherches Scientifique en Côte d'Ivoire

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 juni 2026

Primärt slutförande (Beräknad)

28 februari 2028

Avslutad studie (Beräknad)

28 februari 2028

Studieregistreringsdatum

Först inskickad

15 april 2026

Först inskickad som uppfyllde QC-kriterierna

28 april 2026

Första postat (Faktisk)

6 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 maj 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

28 april 2026

Senast verifierad

1 april 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 2025-50

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • ICF
  • ANALYTIC_CODE

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera